Ambev S.A. Files 6-K Report

TL;DR

Ambev S.A. (ABEV) filed a 6-K, confirming 20-F annual reports and its Brazilian HQ.

AI Summary

Ambev S.A. filed a Form 6-K on November 10, 2025, for the period ending December 31, 2025. The filing is a report of a foreign private issuer and indicates that Ambev S.A. files annual reports under Form 20-F. The company's principal executive office is located in Sao Paulo, Brazil.

Why It Matters

This filing provides an update on Ambev S.A.'s reporting status as a foreign private issuer, which is relevant for investors tracking regulatory compliance and financial reporting schedules.

Risk Assessment

Risk Level: low — This is a routine regulatory filing that does not contain new financial performance data or significant corporate events.

Key Players & Entities

• AMBEV S.A. (company) — Registrant
• 0001292814-25-003875 (filing_id) — Accession Number
• 20251110 (date) — Filing Date
• 20251231 (date) — Report Period End Date
• Sao Paulo, Brazil (location) — Principal Executive Office
• Form 20-F (document_type) — Annual Report Filing
• Form 6-K (document_type) — Current Report Filing

FAQ

Filing Documents

• abevcvm358oct25_6k1.htm (6-K) — 43KB
• 0001292814-25-003875.txt ( ) — 45KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November, 2025 Commission File Number 1565025 AMBEV S.A. (Exact name of registrant as specified in its charter) AMBEV S.A. (Translation of Registrant's name into English) Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F _______ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _______ No ___X____ INDIVIDUAL FORM Article 11 - CVM Instruction # 358/2002 In October 2025: (X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1) ( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows. Company Name: Ambev S.A. Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00 Qualification: Outstanding Shares in Treasury Initial Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 169,205,404 ADR Common 0.00 Transactions in the month Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3) Shares Common Direct with company Delivery of restricted shares 02 33,615 11.99 403,043.85 Final Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 169,171,789 ADR Common 0 (1) When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information, (2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others, (3) Quantity multiplied by price, (*) Each ADR is equivalent to 1 (one) share, SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 10, 2025 AMBEV S.A. By: /s/ Guilherme Fleury de Figueiredo Ferraz Parolari Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer

View Full Filing

View this 6-K filing on SEC EDGAR